189 related articles for article (PubMed ID: 23395452)
1. Targeted delivery of platinum-based anticancer complexes.
Butler JS; Sadler PJ
Curr Opin Chem Biol; 2013 Apr; 17(2):175-88. PubMed ID: 23395452
[TBL] [Abstract][Full Text] [Related]
2. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
[TBL] [Abstract][Full Text] [Related]
3. Targeted Drug Delivery System for Platinum-based Anticancer Drugs.
Gao C; Zhang Y; Chen J; Wang T; Qian Y; Yang B; Dong P; Zhang Y
Mini Rev Med Chem; 2016; 16(11):872-91. PubMed ID: 26586124
[TBL] [Abstract][Full Text] [Related]
4. Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy.
Najjar A; Rajabi N; Karaman R
Curr Pharm Des; 2017; 23(16):2366-2376. PubMed ID: 28155621
[TBL] [Abstract][Full Text] [Related]
5. Platinum formulations as anticancer drugs clinical and pre-clinical studies.
P Farrell N
Curr Top Med Chem; 2011; 11(21):2623-31. PubMed ID: 22039867
[TBL] [Abstract][Full Text] [Related]
6. Platinum(IV) Prodrugs.
Venkatesh V; Sadler PJ
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394022
[TBL] [Abstract][Full Text] [Related]
7. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.
Johnstone TC; Suntharalingam K; Lippard SJ
Chem Rev; 2016 Mar; 116(5):3436-86. PubMed ID: 26865551
[TBL] [Abstract][Full Text] [Related]
8. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects.
Hernández-Gil J; Cobaleda-Siles M; Zabaleta A; Salassa L; Calvo J; Mareque-Rivas JC
Adv Healthc Mater; 2015 May; 4(7):1034-42. PubMed ID: 25846677
[TBL] [Abstract][Full Text] [Related]
9. Anticancer platinum (IV) prodrugs with novel modes of activity.
Chin CF; Wong DY; Jothibasu R; Ang WH
Curr Top Med Chem; 2011; 11(21):2602-12. PubMed ID: 22039869
[TBL] [Abstract][Full Text] [Related]
10. Targeting drug delivery system for platinum(Ⅳ)-Based antitumor complexes.
Zhong Y; Jia C; Zhang X; Liao X; Yang B; Cong Y; Pu S; Gao C
Eur J Med Chem; 2020 May; 194():112229. PubMed ID: 32222677
[TBL] [Abstract][Full Text] [Related]
11. Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin.
Ma R; Wang Y; Yan L; Ma L; Wang Z; Chan HC; Chiu SK; Chen X; Zhu G
Chem Commun (Camb); 2015 May; 51(37):7859-62. PubMed ID: 25854514
[TBL] [Abstract][Full Text] [Related]
12. Fighting the resistance: rejuvenating anticancer platinum-based drugs.
O'Hare A
Nanomedicine (Lond); 2012 Jul; 7(7):947-8. PubMed ID: 23019670
[TBL] [Abstract][Full Text] [Related]
13. Nanocarriers for delivery of platinum anticancer drugs.
Oberoi HS; Nukolova NV; Kabanov AV; Bronich TK
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1667-85. PubMed ID: 24113520
[TBL] [Abstract][Full Text] [Related]
14. Transferrin-functionalized nanographene oxide for delivery of platinum complexes to enhance cancer-cell selectivity and apoptosis-inducing efficacy.
Zhu H; Zhou B; Chan L; Du Y; Chen T
Int J Nanomedicine; 2017; 12():5023-5038. PubMed ID: 28761342
[TBL] [Abstract][Full Text] [Related]
15. Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug.
Razmi M; Divsalar A; Saboury AA; Izadi Z; Haertlé T; Mansuri-Torshizi H
Colloids Surf B Biointerfaces; 2013 Dec; 112():362-7. PubMed ID: 24028849
[TBL] [Abstract][Full Text] [Related]
16. Platinum(iv) anticancer prodrugs - hypotheses and facts.
Gibson D
Dalton Trans; 2016 Aug; 45(33):12983-91. PubMed ID: 27214873
[TBL] [Abstract][Full Text] [Related]
17. The Platin-X series: activation, targeting, and delivery.
Basu U; Banik B; Wen R; Pathak RK; Dhar S
Dalton Trans; 2016 Aug; 45(33):12992-3004. PubMed ID: 27493131
[TBL] [Abstract][Full Text] [Related]
18. Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery.
Ma J; Wang Q; Huang Z; Yang X; Nie Q; Hao W; Wang PG; Wang X
J Med Chem; 2017 Jul; 60(13):5736-5748. PubMed ID: 28603992
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Platinum (IV) Complex-Based Delivery Systems to Improve Platinum (II) Anticancer Therapy.
Han X; Sun J; Wang Y; He Z
Med Res Rev; 2015 Nov; 35(6):1268-99. PubMed ID: 26280923
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents.
Gao X; Liu S; Shi Y; Huang Z; Mi Y; Mi Q; Yang J; Gao Q
Eur J Med Chem; 2017 Jan; 125():372-384. PubMed ID: 27688191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
